TNXP Announces First Participant Dosed in Phase 1 Investigator-Initiated Study of TNX-1900 (Intranasal Potentiated Oxytocin) for Migraine and Craniofacial Pain Treatment
Tonix Pharmaceuticals Holding Corp. · PHARMACEUTICAL PREPARATIONS · Now $12.29
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS